ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,203.70
0.95%
S&P ASX All Technology
3,433.00
1.97%
Brent Oil
70.825
-3.23%
US Dollar vs AUD
1.45084
-1.03%
Bitcoin
65,299.17
3.43%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Precigen Inc (PGEN)

  7. Precigen Inc (PGEN) News

PGEN

Precigen (PGEN)

Precigen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PGEN
DateTimeSourceHeadlineSymbolCompany
17/09/202406:30PR Newswire (US)Precigen to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:PGENPrecigen Inc
31/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
15/08/202406:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
15/08/202406:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
15/08/202406:05PR Newswire (US)Precigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
14/08/202407:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
09/08/202423:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
09/08/202422:00PR Newswire (US)Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14thNASDAQ:PGENPrecigen Inc
09/08/202406:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PGENPrecigen Inc
08/08/202411:30PR Newswire (US)Precigen Announces Pricing of $30.0 Million Public Offering of Common StockNASDAQ:PGENPrecigen Inc
07/08/202406:46Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PGENPrecigen Inc
07/08/202406:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
07/08/202406:04PR Newswire (US)Precigen Announces Proposed $30 Million Public Offering of Common StockNASDAQ:PGENPrecigen Inc
07/08/202406:01PR Newswire (US)Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy LaunchNASDAQ:PGENPrecigen Inc
25/07/202407:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
25/07/202407:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
23/07/202422:01PR Newswire (US)Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy LaunchNASDAQ:PGENPrecigen Inc
03/06/202423:30PR Newswire (US)Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete ResponseNASDAQ:PGENPrecigen Inc
01/06/202409:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
01/06/202409:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
01/06/202409:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
01/06/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
01/06/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
29/05/202406:48Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PGENPrecigen Inc
29/05/202406:44Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PGENPrecigen Inc
24/05/202407:00PR Newswire (US)Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
15/05/202407:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
15/05/202407:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
15/05/202406:05PR Newswire (US)Precigen Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
09/05/202406:05PR Newswire (US)Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
 Showing the most relevant articles for your search:NASDAQ:PGEN

Your Recent History

TSXV
BAU
Blue Star Gold
NASDAQ
CLAC
ASX
DHHF
BetaShares Capital
LSE
72IL
Perm Cust'a'mtg
BITMOT
986514
Eib Tf 2,75% Lg30 Eur
LSE
56ZG
Tower 21-1 64
TG
RZ2
Veralto
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved